|which new medicine looks promising in the pipeline?
May 3, 2004
You and many others have got your eyes glued to new promising treatments in the pipeline? Which ones look nearing approval or of great benefit. Thank you.
| Response from Mr. Vergel
For the first time in a long time, we have several promising treatments for those with few options. Tipranavir is a protease inhibitor in Phase III studies and available through a safety open label program for those under 100 T cells. Another protease enrolling in Phase II is TMC-114. A non nuke , TMC -125 also started enrolling. And the Pfizer and Schering entry inhibitors look very good also, and will start enrolling in Phase II soon. Tanox, a company in Houston, has an IV entry inhibitor that looks very good so far, and studies will start within 6 months in Houston for Phase II. So, in a matter of 2-4 years, we will have more options for the treatment experienced!
For information on each one of these products, visit www.clinicaltrials.gov and type the product name in the search box. It will list all research sites around the US.
Get Email Notifications When This Forum Updates or Subscribe With RSS
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.